scholarly journals A Drosophila ribosomal protein functions in mammalian cells.

1990 ◽  
Vol 10 (9) ◽  
pp. 4524-4528 ◽  
Author(s):  
C G Maki ◽  
D D Rhoads ◽  
J J Diaz ◽  
D J Roufa

A cDNA expression vector encoding Drosophila ribosomal protein S14 was transfected into cultured Chinese hamster ovary (CHO) cells that harbor a recessive RPS14 emetine resistance mutation. Transformants synthesized the insect mRNA and polypeptide and consequently displayed an emetine-sensitive phenotype. These observations indicate that the insect protein was accurately expressed and correctly assembled into functional mammalian 40S ribosomal subunits.

1990 ◽  
Vol 10 (9) ◽  
pp. 4524-4528
Author(s):  
C G Maki ◽  
D D Rhoads ◽  
J J Diaz ◽  
D J Roufa

A cDNA expression vector encoding Drosophila ribosomal protein S14 was transfected into cultured Chinese hamster ovary (CHO) cells that harbor a recessive RPS14 emetine resistance mutation. Transformants synthesized the insect mRNA and polypeptide and consequently displayed an emetine-sensitive phenotype. These observations indicate that the insect protein was accurately expressed and correctly assembled into functional mammalian 40S ribosomal subunits.


Author(s):  
Shazid Md. Sharker ◽  
Md. Atiqur Rahman

Most of clinical approved protein-based drugs or under in clinical trial have a profound impact in the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the biopharmaceutical industry for the mass-production of therapeutic protein. Recent advances in CHO cell bioprocessing to yield recombinant proteins and monoclonal antibodies have enabled the expression of quality protein. The developments of cell lines are possible to upgrade specific productivity. As a result, it holds an interesting area for academic as well as industrial researchers around the world. This review will concentrate on the recent progress of the mammalian CHO cells culture technology and the future scope of further development for the mass-production of protein therapeutics.


2021 ◽  
pp. 2100098
Author(s):  
Benjamin F. Synoground ◽  
Claire E. McGraw ◽  
Kathryn S. Elliott ◽  
Christina Leuze ◽  
Jada R. Roth ◽  
...  

2008 ◽  
Vol 369 (2) ◽  
pp. 712-717 ◽  
Author(s):  
Oleg V. Yarishkin ◽  
Eun-Mi Hwang ◽  
Jae-Yong Park ◽  
Dawon Kang ◽  
Jaehee Han ◽  
...  

2002 ◽  
Vol 79 (5) ◽  
pp. 580-585 ◽  
Author(s):  
Elisabetta G. P. Prati ◽  
Mattia Matasci ◽  
Tobias B. Suter ◽  
Andre Dinter ◽  
Adriana R. Sburlati ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document